NuScale Power Stock Tumbles 15.6% in March: What's Next?
💡 Key Takeaway
NuScale Power's stock decline was driven by disappointing quarterly revenue and a wave of analyst price target cuts, but the long-term thesis for its small modular reactor technology remains intact.
Why NuScale's Stock Dropped
NuScale Power stock continued its rough start to the year, sinking another 15.6% in March according to S&P Global Market Intelligence. This followed a steep 26.5% drop in February, disappointing investors who hoped for a rebound.
The primary trigger was the company's fourth-quarter 2025 financial results, released in late February. Revenue came in at $31.5 million, a 15% decrease from the $37 million reported in the same quarter the previous year. Despite CEO John Hopkins calling 2025 a 'breakthrough year,' the market reacted negatively, sending shares down 3.6% the next day.
Shortly after the earnings report, a series of major Wall Street firms slashed their price targets on the stock. Canaccord Genuity made a dramatic cut, lowering its target to $25 from $60. Goldman Sachs reduced its target to $14 from $20.
The bearish sentiment continued into March. Citigroup lowered its price target to $11.50 from $18.50 while keeping a sell rating, and RBC Capital cut its target to $14 from $21. Two weeks later, UBS joined the chorus, reducing its target to $13 from $20.
This combination of weak financial results and a pessimistic shift from analysts created a powerful headwind that pushed the stock significantly lower throughout the month.
The Bigger Picture for Investors
For current and potential investors, the March sell-off highlights the high volatility and sentiment-driven nature of investing in pre-commercial companies like NuScale. The stock price is highly sensitive to analyst opinions and short-term financial metrics, even when the core long-term story hasn't fundamentally changed.
The revenue decline, while a headline negative, may not be the critical red flag it appears to be. NuScale is still in a pre-revenue, development phase as it works toward launching its first small modular reactor (SMR). The company's value is based on future potential, not current sales.
However, the unanimous downward revisions from analysts signal a loss of confidence on Wall Street regarding the stock's near-term valuation. This can create a negative feedback loop, making it harder for the stock to recover until the company demonstrates tangible progress.
The key takeaway is that NuScale's investment thesis hinges on execution and timelines. The market is punishing the stock for perceived delays or setbacks. The real test will be the company's ability to meet its target of commencing commercial operations by 2030.
Bobby Insight
NuScale is a high-risk, high-potential speculative hold, not a buy for most investors until it shows clearer commercial progress.
The analyst downgrades and revenue miss are serious short-term concerns that justify the stock's decline. However, for investors with a very long time horizon and high risk tolerance, the sell-off may have created an entry point, as the core thesis around SMR leadership remains unproven but unchanged.
What This Means for Me
